Pasithea Therapeutics Stock (NASDAQ: KTTA)

Dernières nouvelles pour Pasithea Therapeutics (NASDAQ:KTTA) Stock

Pasithea Therapeutics

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics Corp

WIIM

MRVL

Marvell shares are trading lower after the company postponed its Investor Day amid uncertainty.

Iamgold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAG#NYSE">IAG</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.09 by 11.11 percent. This is a 9.09 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $477.10 million which missed the analyst consensus estimate of $521.08 million by 8.44 percent. This is a 40.78 percent increase over sales of $338.90 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

Iamgold Q1 Adj. EPS $0.10 Beats $0.09 Estimate, Sales $477.10M Miss $521.08M Estimate

Kimball Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KE#NASDAQ">KE</a>) affirms FY2025 sales outlook from $1.40 billion-$1.44 billion to $1.40 billion-$1.44 billion vs $1.41 billion estimate.

Guidance

Kimball Electronics Affirms FY2025 Sales Guidance of $1.40B-$1.44B vs $1.41B Est

Entrepreneur Grant Cardone is celebrating what he calls the beginning of America&#8217;s biggest comeback ever, thanks to President Donald Trump&#8217;s push to <a href="https://www.benzinga.com/news/25/04/45027945/does-anybody-honestly-believe-manufacturing-is-coming-back-to-the-us-one-person-asked-says-youd-have-to-pay-americans-40-50-hr">bring tech manufacturing back</a> to the U.S.
Cardone <a href="https://x.com/GrantCardone/status/1917726379183071621">posted on X</a> after Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) CEO Jensen Huang joined Trump at the White House on Wednesday to announce a massive new chip investment. &#8220;America is about to have its greatest resurgence in its 250 year history. Thank you President Trump for ‘encouraging' big tech to come home,&#8221; Cardone wrote, sharing a video of Huang&#8217;s remarks.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">America is about to have its greatest resurgence in its 250 year history. Thank you President Trump for "encouraging" big tech to come home. <a href="https://t.co/wQeCwntWxZ">pic.twitter.com/wQeCwntWxZ</a>
&mdash; Grant Cardone (@GrantCardone) <a href="https://twitter.com/GrantCardone/status/1917726379183071621?ref_src=twsrc%5Etfw">April 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">$500 Billion for U.S. Manufacturing</h2>
During the <a href="https://www.youtube.com/watch?v=8aHteOGrtus">event</a>, Trump introduced Huang as &#8220;the founder, CEO and president of NVIDIA,&#8221; and said he was <a href="https://www.benzinga.com/25/04/44799936/nvidia-to-build-500b-ai-infrastructure-in-us-in-the-next-four-years-details">producing up to $500 billion</a> worth of the most powerful AI chips over the next four years—all to be manufactured in the U.S. for the first time ever.
Huang said, &#8220;NVIDIA reinvented computing for the first time after 60 years,&#8221; noting that modern computer design hasn&#8217;t changed much since IBM&#8217;s System/360 in the 1960s. But the new AI chips are a big leap forward.
&#8220;That GPU—that&#8217;s one GPU unit—it&#8217;s 70 pounds, 60,000 parts, 10,000 watts,&#8221; Huang said. &#8220;Just to test a superchip requires a supercomputer.&#8221;
Trending: Donald Trump just announced a $500 billion AI infrastructure deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">here's how you can invest in the entertainment market's next big disruptor at $2.25 per share</a>.
<h2 class="wp-block-heading">AI Chips Made in America</h2>
Huang credited Trump for pushing manufacturing to happen in the U.S. &#8220;Without the president&#8217;s leadership, his policies, his support, and very importantly, his strong encouragement … manufacturing in the United States wouldn&#8217;t have accelerated to this pace,&#8221; he said.
He emphasized that making these chips isn&#8217;t about cheap labor—it&#8217;s about advanced tech, robotics, and AI. Nvidia will also use its Omniverse digital twin technology to help build cutting-edge factories on U.S. soil.
&#8220;This new industry is a manufacturing industry in itself,&#8221; Huang said. &#8220;We now have the backing of the administration, the backing of President Trump, to support the creation of a whole new industry.&#8221;
See Also: Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — Don't repeat history—<a href="https://www.benzinga.com/money/big-tech-has-spent-billions-acquiring-ai-smart-home-startups-one-company-stands-to-benefit-and-has-already-made-10-million">invest in RYSE at just $1.90/share.</a>
<h2 class="wp-block-heading">A Future Built on AI</h2>
Huang said the AI infrastructure being built in the U.S. will power breakthroughs in healthcare, financial services, drug discovery, education, and more.
&#8220;This computer is the engine of a whole new industry,&#8221; he said. &#8220;Electricity goes into this machine and incredible tokens come out—artificial intelligence.&#8221;
Nvidia&#8217;s partnership with the Trump administration may be shaping up to be a key turning point in <a href="https://www.benzinga.com/news/global/25/04/45082716/manufacturing-momentum-market-mirage-lutnick-dismisses-recession">bringing high-tech manufacturing back</a> to the U.S., and Cardone believes it could mark the beginning of a historic economic transformation.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market">Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

NVDA

Grant Cardone Says, 'America About To Have Greatest Resurgence In Its 250-Year History,' Thanks Trump For Encouraging Big Tech To Come Home

Kimball Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KE#NASDAQ">KE</a>) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.19 by 42.11 percent. This is a 20.59 percent decrease over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $374.61 million which beat the analyst consensus estimate of $338.08 million by 10.80 percent. This is a 11.86 percent decrease over sales of $425.04 million the same period last year.

Kimball Electronics Q3 Adj. EPS $0.27 Beats $0.19 Estimate, Sales $374.61M Beat $338.08M Estimate

LOMA

Loma Negra Cia Industria Q1 EPS $0.17, Sales $149.00M

Ovintiv (TSX:<a class="ticker" href="https://www.benzinga.com/stock/OVV#TSX">OVV</a>) reported quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.18 by 20.34 percent. This is a 0.7 percent decrease over earnings of $1.43 per share from the same period last year. The company reported quarterly sales of $2.38 billion which beat the analyst consensus estimate of $2.29 billion by 3.80 percent. This is a 1.06 percent increase over sales of $2.35 billion the same period last year.

TSX:OVV

Ovintiv Q1 Adj. EPS $1.42 Beats $1.18 Estimate, Sales $2.38B Beat $2.29B Estimate

Manitowoc Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTW#NYSE">MTW</a>) affirms FY2025 Adj EPS guidance from $0.15-$0.85 to $0.15-$0.85 vs $0.45 analyst estimate. Affirms FY2025 sales outlook from $2.17 billion-$2.27 billion to $2.17 billion-$2.27 billion vs $2.18 billion estimate.

Manitowoc Co Affirms FY2025 Adj EPS Guidance of $0.15-$0.85 vs $0.45 Est; Affirms FY2025 Sales Guidance of $2.17B-$2.27B vs $2.18B Est

Ovintiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OVV#NYSE">OVV</a>) reported quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.05 by 35.24 percent. This is a 0.7 percent decrease over earnings of $1.43 per share from the same period last year. The company reported quarterly sales of $2.38 billion which beat the analyst consensus estimate of $2.18 billion by 9.18 percent. This is a 1.06 percent increase over sales of $2.35 billion the same period last year.

Ovintiv Q1 Adj. EPS $1.42 Beats $1.05 Estimate, Sales $2.38B Beat $2.18B Estimate

BofA Securities analyst Jeffrey Spector downgraded Lineage Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) to Neutral from Buy on Tuesday and lowered the price forecast <a target="_blank" href="https://www.benzinga.com/quote/LINE/analyst-ratings" rel="noreferrer noopener">from $70.00 to $49.00</a>.
The analyst downgraded LINE and lowered the price target, citing reduced visibility driven by persistent revenue growth challenges, halted supply chain investments, and downward earnings revisions.
Spector noted that producers are delaying key decisions on expansions, plant locations, and transportation sourcing due to macroeconomic uncertainty driven by tariffs.
Lineage reported first-quarter 2025 EPS of $0.01, exceeding analyst expectations of a $ 0.05 loss, and posted revenue of $1.29 billion, which fell short of the $1.34 billion consensus estimate.
The Company <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45093641/lineage-inc-announces-first-quarter-2025-financial-results-and-landmark-agreements-with-long-term-" rel="noreferrer noopener">maintains its full-year 2025</a> outlook, projecting adjusted EBITDA between $1.35 billion and $1.40 billion, and adjusted FFO per share in the range of $3.40 to $3.60.
The analyst stated that Lineage reported Q1 AFFO of $0.86, surpassing both their $0.80 estimate and the $0.85 consensus. However, revenue declined 4.2% compared to their projected 2.1% growth, driven by lower occupancy, reduced throughput volumes, and softer pricing in both storage and services.
Spector added that the 2025 AFFO guidance was upheld, partly due to recent acquisitions, including the Tyson Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45093569/lineage-inc-announces-plans-to-expand-its-u-s-cold-storage-network-with-long-time-customer" rel="noreferrer noopener">deal</a>.
The analyst lowered the 2025 occupancy growth forecast to -1.7% from -0.6% and reduced 2025 throughput volume growth to -1.6% from +1.5%. 2026 occupancy growth remains flat, with throughput growth revised down to +0.3% from +1.5%.
The analyst revised 2025 occupancy growth down to -1.7% from -0.6%, and reduced throughput volume growth to -1.6% from +1.5%. For 2026, occupancy growth is expected to remain flat, while throughput growth is now forecasted at +0.3%, down from +1.5%.
Here are other recent <a target="_blank" href="https://www.benzinga.com/quote/LINE/analyst-ratings" rel="noreferrer noopener">analyst ratings</a> on Lineage and their price targets:
<ul>
<li>Piper Sandler: Maintained an Overweight rating, lowered price target from $75 to $60</li>
<li>Baird: Maintained Outperform rating, lowered price target from $70 to $64</li>
<li>Evercore ISI Group: Maintained an Inline rating, lowered price target from $68 to $59</li>
<li>UBS: Maintained Neutral rating, lowered price target from $62 to $49</li>
</ul>
Price Action: LINE shares closed lower by 1.13% to $43.78 on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45238222/teslas-future-hinges-on-china-fsd-analyst-says" target="_blank" rel="noreferrer noopener">Tesla&#8217;s Future Hinges On China FSD: Goldman Sachs</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Downgrades

Price Target

Analyst Ratings

Movers

Trading Ideas

LINE

Lineage Stock Forecast Slashed By 30% - Here's Why

Arista Networks, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) released its first-quarter results after Tuesday's closing bell. Here's a look at the key details <a href="https://www.benzinga.com/pressreleases/25/05/b45235091/arista-networks-inc-reports-first-quarter-2025-financial-results">from the quarter. </a>
The Details: Arista Networks reported quarterly earnings of 65 cents per share, which beat the analyst consensus estimate of 60 cents. Quarterly revenue came in at $2 billion, which missed the consensus estimate of $2.02 billion.
Non-GAAP gross margin was 64.1%, compared to 64.2% in the fourth quarter of 2024. 
Read Next:&nbsp; <a href="https://www.benzinga.com/news/legal/25/05/45226604/president-trump-wants-to-reopen-alcatraz-heres-what-it-would-take?utm_source=articleShare">President Trump Wants To Reopen Alcatraz: Here&#8217;s What It Would Take</a>
&#8220;As we enter 2025, AI, cloud, and enterprise customers continue to drive network transformation. We surpassed $2 billion in revenue for the first time in Q1 2025 despite the unknowns around tariffs,&#8221; stated Jayshree Ullal, CEO of Arista Networks. &#8220;Arista&#8217;s trifecta of innovation, growth and profitability is reflected in our results.&#8221;
Outlook:&nbsp;Arista Networks sees second-quarter revenue of $2.1 billion, versus the $2.11 billion estimate. 
ANET Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Arista Networks stock was down 7.35% after hours at $84 on Tuesday.  
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45228179/upwork-delivers-solid-start-to-2025-analyst?utm_source=articleShare">Upwork Delivers &#8216;Solid Start To 2025&#8217;: Analyst&nbsp;</a></li>
</ul>
Photo: Shutterstock

After-Hours Center

Tech

ANET

Arista Networks Shares Fall After Mixed Q1 Results: EPS Beat, Revenues Miss, Q2 Guidance Below Estimates

MEG Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/MEG#TSX">MEG</a>) reported quarterly earnings of $0.82 per share which beat the analyst consensus estimate of $0.61 by 34.43 percent. This is a 127.78 percent increase over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $1.16 billion which missed the analyst consensus estimate of $1.39 billion by 16.40 percent. This is a 14.81 percent decrease over sales of $1.36 billion the same period last year.

TSX:MEG

MEG Energy Q1 EPS $0.82 Beats $0.61 Estimate, Sales $1.16B Miss $1.39B Estimate

"We have decided to postpone our investor day given the current uncertain macroeconomic environment. At the same time, we continue to make great progress in our custom AI silicon business and look forward to sharing updates on the expanded opportunities since our AI Day a year ago," said Matt Murphy, Marvell's Chairman and CEO. "This topic is central to our annual senior technical leadership conference in Santa Clara on June 17th and 18th, making it an ideal time to engage with the investment community through a focused webinar."
Reaffirming Midpoint of Fiscal First Quarter 2026 Revenue Outlook and Narrowing Guidance Range
The Company also reaffirmed the midpoint of its revenue outlook for the first quarter of fiscal 2026, as previously provided on March 5, 2025, and announced a narrower guidance range. Net revenue is now expected to be approximately $1.875 billion, within a range of +/- 2%, compared to the prior range of +/- 5%. &nbsp;

Marvell Postpones Investor Day Due To Macroeconomic Uncertainty; Reaffirms Midpoint Of Its Revenue Outlook For Q1 2026, As Previously Provided On March 5, 2025, And Announced A Narrower Guidance Range; Net Revenue Is Now Expected To Be ~$1.875B, Within A Range Of +/- 2%, Compared To The Prior Range Of +/- 5%

Loma Negra Cia Industria (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOMA#NYSE">LOMA</a>) reported $149.00 million in sales this quarter. This is a 8.11 percent increase over sales of $137.82 million the same period last year.

Loma Negra Cia Industria Q1 Sales $149.00M Up From $137.82M YoY

Minto Apartment (TSX:<a class="ticker" href="https://www.benzinga.com/stock/MI#TSX">MI</a>) reported quarterly earnings of $0.20 per share. This is a 3.92 percent decrease over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $38.01 million which missed the analyst consensus estimate of $39.30 million by 3.28 percent. This is a 2.40 percent decrease over sales of $38.94 million the same period last year.

TSX:MI

Minto Apartment Q1 FFO $0.196 Down From $0.20 YoY, Sales $38.01M Down from 38.943M YoY

Rosenblatt analyst Kevin Cassidy revised estimates for Navitas Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) following the first quarter results reported on Monday.
The company reported an adjusted EPS loss of 6 cents, which was in line with estimates, and sales reached $14.02 million, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45206260/navitas-semiconductor-announces-first-quarter-2025-financial-results" rel="noreferrer noopener">exceeding the estimated $13.99 million</a>.
Navitas Semiconductor expects second quarter sales of $14 million &#8211; $15 million <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">vs consensus of $14.95 million</a>.
The analyst says that the results and guidance for the second quarter of 2025 were largely in line with expectations.
The analyst adds that the adoption of Gallium Nitride (GaN) technology in end markets beyond handsets continues to be slower than anticipated and is still working through existing Silicon Carbide (SiC) inventory.
The analyst writes that the company is securing new design wins, with particular optimism on the recently launched GaN bi-directional diode switch.
Cassidy expects production ramps for solar microinverter applications in the second half of 2025.
While tariffs are not currently a direct impediment to demand, management expressed caution regarding the second half of 2025 and has contingency plans in place for China-for-China and USA-for-USA, adds the analyst.
For FY25, the analyst estimates revenues of $60.5 million (vs. consensus of $74.5 million) and an adjusted EPS loss of $0.19 (vs. consensus loss of $0.16), down from the earlier estimate of $75 million and a loss of $0.16, respectively.
For FY26, Cassidy continues to estimate revenue of $110 million and an adjusted EPS loss of $0.07.
Price Action: NVTS shares closed lower by 4.74% at $1.91 on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/44474207" target="_blank" rel="noreferrer noopener">Canadian Solar Posts Wider Q4 Loss, Reaffirms 2025 Outlook Amid Fierce Industry Headwinds</a></li>
</ul>
Photo via Shutterstock

Equities

Large Cap

Reiteration

NVTS

Navitas GaN Adoption Is Slower Than Anticipated: Analyst

The board of directors of Ashland Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock which represents a 2.5 percent increase from the previous quarter. The dividend will be payable on June 15, 2025, to stockholders of record at the close of business on June 1, 2025.
As of April 30, 2025, there were 45,696,225 shares of Ashland common stock outstanding.

Dividends

Ashland Increases Quarterly Dividend From $0.41 To $0.415 Per Share

Honeywell Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) has outperformed the market over the past 20 years by 1.3% on an annualized basis producing an average annual return of 9.5%. Currently, Honeywell Intl has a market capitalization of $135.04 billion. 
Buying $1000 In HON: If an investor had bought $1000 of HON stock 20 years ago, it would be worth $6,079.79 today based on a price of $209.93 for HON at the time of writing.
<h3>Honeywell Intl's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746566121_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Wynn Resorts, Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>) reported first-quarter financial results Tuesday after the bell. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/05/b45234840/wynn-resorts-limited-reports-first-quarter-2025-results">of the report</a>.
<ul>
<li>Q1 Revenue: $1.7 billion, versus <a href="https://www.benzinga.com/quote/WYNN/earnings">estimates</a> of $1.74 billion</li>
</ul>
<ul>
<li>Q1 Adjusted EPS: $1.07, versus estimates of $1.19</li>
</ul>
Total revenue was down from $1.86 billion in the first quarter of 2024. Operating revenue at Wynn Macau fell $81.8 million in the quarter, Wynn Palace revenue declined $51 million, Las Vegas revenue dropped $11.3 million and Boston Harbor revenue was down $8.6 million. 
Wynn Resorts ended the quarter with $2.07 billion in cash and cash equivalents, as well as $10.55 billion in current and long-term debt outstanding. 
&#8220;In Las Vegas, where we recently celebrated the resort&#8217;s 20th anniversary, the team delivered healthy results against a record prior year comparison, which reflected the Las Vegas Super Bowl. In Macau, while VIP hold negatively impacted results, we held market share in our expected range, and announced an increased dividend from Wynn Macau, Limited, reflecting the strong free cash flow generated by the business,&#8221; said Craig Billings, CEO of Wynn Resorts.
See Also: <a href="https://www.benzinga.com/news/earnings/25/05/45237261/amd-q1-earnings-revenue-eps-beat-driven-by-expanding-data-center-ai-momentum-chipmaker-expects-strong-growth-in-2025">AMD Q1 Earnings: Revenue, EPS Beat Driven By Expanding Data Center, AI Momentum, Chipmaker Expects &#8216;Strong Growth&#8217; In 2025</a>
Wynn noted that it repurchased $200 million worth of its stock during the quarter, and had $613 remaining under its buyback as of March 31. The company&#8217;s board also declared a cash dividend of 25 cents per share, payable on May 30 to shareholders of record as of May 16. 
Wynn highlighted progress at its growth project in the United Arab Emirates, Wynn Al Marjan Island. The company said it continued to advance construction in the quarter with progress reaching the 47th floor. 
Wynn executives are currently discussing the quarter on a conference call that kicked off at 4:30 p.m. ET.
WYNN Price Action: <a href="http://benzinga.com/quote/wynn">Wynn Resorts shares</a> were down 2.42% in extended trading on Tuesday, trading at $81.50 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://in.benzinga.com/25/05/45207560/expedia-faces-turbulence-as-us-travel-trend-weakens-says-analyst">Expedia Faces Turbulence As US Travel Trend Weakens, Says BofA Analyst</a></li>
</ul>
Photo: Ceri Breeze/Shutterstock.

Entertainment

WYNN

Wynn Resorts Misses Q1 Earnings Estimates, Shares Slide

Lattice Semiconductor Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) stock fell on Tuesday.
The company reported its <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45208613/lattice-semiconductor-shares-slide-after-q1-results-details" rel="noreferrer noopener">first-quarter results</a> after Monday&#8217;s closing bell<a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45205997/lattice-semiconductor-reports-first-quarter-2025-results" rel="noreferrer noopener">, </a>clocking a quarterly earnings of 22 cents per share, which aligns with the analyst consensus estimate.
Quarterly revenue was $120.15 million (down from $140.81 million Y/Y), which beat the analyst consensus estimate of $120.13 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45208613/lattice-semiconductor-shares-slide-after-q1-results-details" rel="noreferrer noopener">Lattice Semiconductor Shares Slide After Q1 Results: Details</a>
Lattice Semiconductor expects second-quarter adjusted earnings of between 22 cents and 26 cents per share, versus the 24 cents estimate, and revenue of&nbsp;$118.5 million-$128.5 million, versus the&nbsp;$123.61 million&nbsp;analyst estimate.
Wall Street analysts rerated the stock after the quarterly report.
Rosenblatt analyst Kevin Garrigan maintained a Buy rating on Lattice Semiconductor with a <a target="_blank" href="https://www.benzinga.com/quote/LSCC/analyst-ratings" rel="noreferrer noopener">price forecast of $72</a>.
Growth across Industrial &amp; Automotive and Consumer end-markets drove the sequential revenue increase, while Communications &amp; Computing declined slightly. Additionally, design win momentum remained at record levels. The adjusted gross margin was 69% (+700bps Q/Q, flat Y/Y), which aligns with Garrigan&#8217;s 69.0% estimate and slightly below the consensus 70.1% estimate.
Management reiterated its U-shaped recovery and expects low single-digit Y/Y revenue growth in 2025.
The company continues to ship below true demand in the near term and is encouraged by continued booking improvement. Channel inventory also continues to decrease.
Management commented that they do not see any material impact from tariffs but are more cautious about the effect in the second half of 2025.
Additionally, ~80% of Lattice&#8217;s revenue comes from outside the US, and Lattice has a diversified global supply chain, helping mitigate any direct impacts from tariffs.
Management expects continued recoveries in Industrial &amp; Automotive markets and growth in Communications &amp; Computing.
Garrigan continues to recommend Lattice Semiconductor shares for its robust design win pipeline, new product momentum, and share gains in the small/mid-FPGA market.
Garrigan projected second-quarter revenue of $123.5 million and EPS of $0.24.
Price Action: LSCC stock closed lower by 12.7% at $45.82 on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45196679/nvidia-faces-new-challenges-as-us-tightens-semiconductor-sanctions-and-tracks-ai-chip-smuggling" target="_blank" rel="noreferrer noopener">Nvidia&#8217;s New Challenge: US Lawmaker Wants Company To Track Its Chips To Avoid Smuggling In China</a></li>
</ul>
Photo via Shutterstock

LSCC

Why Did Lattice Semiconductor Stock Plunge On Tuesday?

Health Care

Press Releases

Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

Pasithea Therapeutics Announces Opening of European Clinical Trial Sites and Completes Initial Dosing of Cohort 4

Power Nickel's (TSX.V: PNPN) Hole Delivers "BIG"- Gold Terra (TSX.V: YGT) Developments and Exploration Progress Reported – More Stocks Inside!

Pasithea Therapeutics to Present at the 2025 CAGLA NeauxCancer Conference

Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its Ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

Pasithea Therapeutics to Present Updated Data from Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients at the 2025 ASCO Annual Meeting

Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Patients in Cohort 6 from its Phase 1 Trial of PAS-004 in Advanced Cancer Patients

Pasithea Therapeutics Reports Positive Pharmacodynamic Results Demonstrating Robust Target Engagement from its Ongoing Phase 1 Clinical Trial of PAS-004

Pasithea Therapeutics Announces Pricing of $5 Million Public Offering

KTTA

KTTAW

OGEN

PNPNF

TSXV:PNPN

TSXV:YGT

YGTFF

Alzamend Neuro

Azitra

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Ensysce Biosciences

Galecto

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Mustang Bio

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Oragenics

Palisade Bio

Psyence Biomedical Ltd. - Ordinary Shares

Psyence Biomedical

Plus Therapeutics

Sunshine Biopharma

SILO Pharma

Synaptogenix

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Tharimmune

Theriva Biologics

VivoSim Labs

Windtree Therapeutics, Inc. - Common Stock

Comments

Pasithea Therapeutics

Actualités

Dernières nouvelles pour Pasithea Therapeutics (NASDAQ:KTTA) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL